Cargando…

Viral membrane fusion

Infection by viruses having lipid-bilayer envelopes proceeds through fusion of the viral membrane with a membrane of the target cell. Viral 'fusion proteins' facilitate this process. They vary greatly in structure, but all seem to have a common mechanism of action, in which a ligand-trigge...

Descripción completa

Detalles Bibliográficos
Autor principal: Harrison, Stephen C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517140/
https://www.ncbi.nlm.nih.gov/pubmed/18596815
http://dx.doi.org/10.1038/nsmb.1456
_version_ 1782158513038950400
author Harrison, Stephen C
author_facet Harrison, Stephen C
author_sort Harrison, Stephen C
collection PubMed
description Infection by viruses having lipid-bilayer envelopes proceeds through fusion of the viral membrane with a membrane of the target cell. Viral 'fusion proteins' facilitate this process. They vary greatly in structure, but all seem to have a common mechanism of action, in which a ligand-triggered, large-scale conformational change in the fusion protein is coupled to apposition and merger of the two bilayers. We describe three examples—the influenza virus hemagglutinin, the flavivirus E protein and the vesicular stomatitis virus G protein—in some detail, to illustrate the ways in which different structures have evolved to implement this common mechanism. Fusion inhibitors can be effective antiviral agents.
format Text
id pubmed-2517140
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-25171402009-01-01 Viral membrane fusion Harrison, Stephen C Nat Struct Mol Biol Article Infection by viruses having lipid-bilayer envelopes proceeds through fusion of the viral membrane with a membrane of the target cell. Viral 'fusion proteins' facilitate this process. They vary greatly in structure, but all seem to have a common mechanism of action, in which a ligand-triggered, large-scale conformational change in the fusion protein is coupled to apposition and merger of the two bilayers. We describe three examples—the influenza virus hemagglutinin, the flavivirus E protein and the vesicular stomatitis virus G protein—in some detail, to illustrate the ways in which different structures have evolved to implement this common mechanism. Fusion inhibitors can be effective antiviral agents. Nature Publishing Group US 2008-07-03 2008 /pmc/articles/PMC2517140/ /pubmed/18596815 http://dx.doi.org/10.1038/nsmb.1456 Text en © Nature Publishing Group 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Harrison, Stephen C
Viral membrane fusion
title Viral membrane fusion
title_full Viral membrane fusion
title_fullStr Viral membrane fusion
title_full_unstemmed Viral membrane fusion
title_short Viral membrane fusion
title_sort viral membrane fusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517140/
https://www.ncbi.nlm.nih.gov/pubmed/18596815
http://dx.doi.org/10.1038/nsmb.1456
work_keys_str_mv AT harrisonstephenc viralmembranefusion